Details for New Drug Application (NDA): 009660
✉ Email this page to a colleague
NDA 009660 describes NOLUDAR, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the NOLUDAR profile page.
The generic ingredient in NOLUDAR is methyprylon. Additional details are available on the methyprylon profile page.
The generic ingredient in NOLUDAR is methyprylon. Additional details are available on the methyprylon profile page.
Summary for 009660
| Tradename: | NOLUDAR |
| Applicant: | Roche |
| Ingredient: | methyprylon |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 50MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
